Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastoma. is a research paper published in UNC Libraries (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 2R01CA140198-06
Targeting Oncogenic ALK Signaling in Neuroblastoma
National Institutes of Health
Grant: 5U24DK116204-04
Illuminating Function of the Understudied Druggable Kinome
National Institutes of Health
Grant: 3P30CA016086-42S2
Cancer Center Support Grant
Fields of Study
Keywords